NDC 70748-153 – Penicillamine
Penicillamine 250 mg/1 · Tablet · Oral
Product NDC70748-153
Product details
- Brand name
- Penicillamine
- Generic name
- Penicillamine
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA212933
- Marketed since
- March 1, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Antirheumatic Agent
Active ingredients
- Penicillamine 250 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70748-153-01 | 100 TABLET in 1 BOTTLE (70748-153-01) | Mar 1, 2021 |
Recalls mentioning this NDC
- D-0148-2024 Dec 20, 2023 · Class II
Failed Dissolution Specifications
Other Penicillamine products
- 0591-4171 Penicillamine 250 mg/1 · Capsule · Actavis Pharma, Inc.
- 51991-974 Penicillamine 250 mg/1 · Capsule · Breckenridge Pharmaceutical, Inc.
- 43598-634 Penicillamine 250 mg/1 · Capsule, Gelatin Coated · Dr. Reddy's Laboratories Inc.
- 70010-907 Penicillamine 250 mg/1 · Capsule · Granules Pharmaceuticals Inc.
- 68475-201 Penicillamine 250 mg/1 · Capsule · Navinta LLC
- 0254-2000 Penicillamine 250 mg/1 · Tablet, Film Coated · Par Health USA, LLC
- 49884-146 Penicillamine 250 mg/1 · Capsule · Par Health USA, LLC
- 71205-916 Penicillamine 250 mg/1 · Capsule · Proficient Rx LP